PMC:7200337 / 35737-36199
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T366 | 135-142 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T367 | 180-183 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
| T368 | 235-243 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T369 | 336-341 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T370 | 348-355 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T237 | 88-92 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T425 | 57-64 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T426 | 287-288 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T427 | 322-325 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
| T428 | 330-333 | http://purl.obolibrary.org/obo/CLO_0053438 | denotes | CD8 |
| T429 | 334-341 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T172 | 57-64 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T173 | 135-142 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T174 | 192-194 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
| T175 | 235-243 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T176 | 248-255 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
| T177 | 348-355 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1186 | 322-325 | Gene | denotes | CD4 | Gene:920 |
| 1187 | 330-333 | Gene | denotes | CD8 | Gene:925 |
| 1208 | 346-347 | Gene | denotes | S | Gene:43740568 |
| 1209 | 133-134 | Gene | denotes | S | Gene:43740568 |
| 1222 | 88-98 | Species | denotes | SARS-Cov-2 | Tax:2697049 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T198 | 0-462 | Sentence | denotes | This study is notable for the use of large complementary peptide pools comprising 1,095 SARS-Cov-2 epitopes (overlapping 15-mers for S protein as well as computationally predicted HLA-I- and -II-restricted epitopes for all other viral proteins) as antigen-specific stimuli that revealed a preferential specificity of both CD4 and CD8 T cells for S protein epitopes, with the former population modestly increasing over ∼10–30 days after initial onset of symptoms. |